Top

Published in:

01-06-2003

Effect of Ligands of Nuclear Hormone Receptors on Sodium/Iodide Symporter Expression and Activity in Breast Cancer Cells

Authors: Sakae Tanosaki, Takayuki Ikezoe, Anthony Heaney, Jonathan W. Said, Kazuo Dan, Makoto Akashi, H. Phillip Koeffler

Published in: Breast Cancer Research and Treatment | Issue 3/2003

Title: Effect of Ligands of Nuclear Hormone Receptors on Sodium/Iodide Symporter Expression and Activity in Breast Cancer Cells
Authors: Sakae Tanosaki
Takayuki Ikezoe
Anthony Heaney
Jonathan W. Said
Kazuo Dan
Makoto Akashi
H. Phillip Koeffler
Publication date: 01-06-2003
Publisher: Kluwer Academic Publishers
Published in: Breast Cancer Research and Treatment / Issue 3/2003
Print ISSN: 0167-6806
Electronic ISSN: 1573-7217
DOI: https://doi.org/10.1023/A:1024064424855

Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras

Prof. Fabrice Barlesi

Developed by: Springer Medicine

At a glance: The STEP trials

Springer Medicine

Please log in to get access to this content

Other articles of this Issue 3/2003

HER2 Codon 655 Polymorphism and Risk of Breast Cancer in African Americans and Whites

Instructions for Authors

Inositol Hexaphosphate (IP6) Enhances the Anti-Proliferative Effects of Adriamycin and Tamoxifen in Breast Cancer

Incidence of Anaemia in Breast Cancer Patients Receiving Adjuvant Chemotherapy

Ornithine Decarboxylase (ODC) as a Prognostic Factor in Operable Breast Cancer

Role of CRE-Binding Protein (CREB) in Aromatase Expression in Breast Adipose

Keynote webinar | Spotlight on antibody–drug conjugates in cancer